Zacks.com featured highlights include DaVita, Integra LifeSciences, Braskem and LyondellBasell DaVita, Integra, Braskem and LyondellBasell screen as attractive GARP stocks, combining growth potential with discounted PEG ratios.…
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Integra (IART) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates Integra (IART) delivered earnings and revenue surprises of +4.73% and +0.13%, respectively, for the quarter ended December 2025. Do the…
Earnings call transcript: Integra LifeSciences Q3 2025 beats EPS expectations By Investing.com Earnings call transcript: Integra LifeSciences Q3 2025 beats EPS expectations…
Integra LifeSciences Reports Third Quarter 2025 Financial Results PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical…
Integra (IART) Q2 Revenue Beats by 5% Key PointsIntegra LifeSciences (NASDAQ:IART) delivered GAAP revenue of $415.6 million in Q2 2025, beating analyst estimates by $20.6 million (GAAP)…
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations…
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology…
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology…
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology…
Amniotic Products Market: $900M to $1,289M Growth Forecast (2023-2028) | MarketsandMarkets™ Chicago, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Amniotic Products Market Size, Share & Trends by Type (Cryopreserved…
Integra LifeSciences Reports Second Quarter 2024 Financial Results PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical…
Integra LifeSciences revenue tops consensus in Q1, earnings in-line By Investing.com Integra LifeSciences revenue tops consensus in Q1, earnings in-line…
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology…
Integra LifeSciences (IART) Introduces MicroMatrix Flex Integra LifeSciences (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM)…
Truist cuts Integra LifeSciences target to $41 on outlook concerns By Investing.com Truist cuts Integra LifeSciences target to $41 on outlook concerns…
Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates Integra (IART) delivered earnings and revenue surprises of -1.11% and 0.44%, respectively, for the quarter ended December 2023. Do the…